The following are examples of non- validated quality metrics that could be used by individual providers, health care systems, or multi-center quality improvement collaboratives to support implementation of the American Academy of Pediatrics guideline for Opioid Prescribing. These metrics reflect several key aspects of care for common clinical issues. A subset of these metrics or entirely different metrics could also be selected.
If you have any questions or comments, contact us.
Studies have reported inequities in opioid prescribing and related outcomes. The following examples illustrate possible clinical populations for each measure.
*Stratify by health equity measures such as, but not limited to, race and ethnicity, preferred language, sex and gender, and insurance type.
^In calculating the denominator for these measures, reference the literature available for specific clinical populations. Compare to other institutions’ prescribing practices for specific clinical populations.
Amy Bryl, MD, FAAP, is Associate Clinical Professor of Pediatrics at the University of California San Diego and Director of Quality for Children's Specialists of San Diego and the Division of Emergency Medicine at Rady Children's Hospital San Diego. She was the implementation scientist on the recently published American Academy of Pediatrics Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline.
Last Updated
01/14/2025
Source
American Academy of Pediatrics